Eversheds in largest pharmaceutical patent infringement award in Spanish history
Eversheds’ Madrid office has successfully represented pharmaceutical company MSD Spain in a landmark patent dispute, setting a new precedent for patent infringement cases.
The Madrid Commercial Court ordered generic drug companies Chemo Iberica and Quimica Sintetica to pay MSD Spain damages of €20m (£16m) for infringement of the Losartan patent. Losartan is commercially known as the hypertension medication Cozaar.
This ground-breaking decision represents the largest pharmaceutical patent infringement award in Spanish judicial history.
The Eversheds Nicea team, led by partners Kiko Carrión and José Mariano Cruz, acted for MSD Spain.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
The Pensions Regulator has published a new code of practice on funding defined benefits ’to minimise any adverse impact on the sustainable growth of an employer’.
On 8 April 2014, the European Court of Justice in the Digital Rights Ireland case declared the Data Retention Directive 2006/24/EC invalid
Analysis from The Lawyer
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe